SPDL1 and cancer: When the sPD-L1 level increases in the body, it can bind more to the sPD-1 receptor, inhibit T-cell proliferation and differentiation and induce apoptosis, suppressing the normal immune system, making malignant proliferating tumor cells escape immune killing, resulting in the obstruction of the apoptosis process of cancer.